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Transforming growth factor beta-t (TGF-ftt) has been 
shown to inhibit keratinocyte proliferation in vitro yet 
to stimulate wound healing in vivo. To explore this 
apparent paradox, the effect of TGF-fit on prolifera-
tion and migration was investigated in organotypic 
cultures after incisional wounding. Organotypic cul-
tures provide a more in vivo -like epidermal tissue and 
may therefore respond in a different manner than 
previous culture models in which epidermal differen-
tiation is incomplete. 
Without TGF-ftt, keratinocytes were hyperprolifer-
ative in response to wounding. At doses of2.5 ngjmlor 
greater, a delay in re-epithelialization was seen at 24 h 
post-wounding along with a reduction in hyperpro-
T ransforming growth factor beta-1 (TGF-P1) has been shown to affect the cellular proliferation, differentia-tion, and gene expression of all major cell types in-volved in wound healing ill vivo [1]. This growth fac-tor is a mitogen for fibroblasts and endothelial cells 
and is thought to enhance wound healing in vivo through these 
effects [2- 8]. On the other hand, TGF-p1 inhibits keratinocyte 
proliferation in submerged cultures [9 - 11] and in transgenic mice 
overexpressing this growth factor [12]. 
One possible explanation for this paradox is that wounded kerati-
nocytes are activated after injury and are not subject to the same 
regulatory controls as non-wounded keratinocytes [3]. An alterna-
tive explanation is that the TGF-pl influence on wound repair ill 
villa is mediated in part by paracrine-acting factors produced by 
underlying connective tissue [10,13]. This marked difference be-
tween the in vivo actions of TGF-pl and those in an isolated cell 
system has been related to the multifunctional nature of this cyto-
kine and the context in which it has its effects [14] . 
Due to these varied effects of TGF-pl on keratinocytes, ill vivo 
systems have addressed the dose effect of TGF-p1 on the wound-
healing process. Variations in TGF-p1levels have been determined 
in rat wounds [15] and may playa role in the temporal regulation of 
wound healing. Elevated doses of TGF-p1 have been shown to 
retard epithelial regeneration in split thickness cutaneous pig 
wounds [4] and to inhibit this process in full-thickness rabbit 
wounds [16,17]. On the other hand, low doses ofTGF-p1 either 
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liferation. By 48 h, however, re-epithelialization was 
complete in all cultures treated with TGF-ft1. In par-
ticular, 7 ngjml TGF-ftt inhibited proliferation yet 
had no effect on re-epithelialization by 48 h. These 
studies demonstrate that i) TGF-ftt induced a delay in 
re-epithelialization, ii) proliferation of wounded ker-
atinocytes was not inhibited at 2.5 ngjml doses of 
TGF-ftt, and iii) at 7 ngjml TGF-ftt, re-epithelializa-
tion was complete by 48 h in spite of the profound 
inhibition of cell proliferation. In the organotypic 
model, TGF-ftt appears to alter re-epithelialization. 
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stimulate epithelial regeneration [3,6,7,11] or have little effect on 
this process [2,13,18] in these same ill vivo models. The role of 
TGF-p1 on re-epithelialization fo llowing wounding remains unre-
solved [19] . 
We have developed a model for in vitro re-epithelialization by 
adapting an organotypic culture model [20,21] that demonstrates a 
basal proliferation rate for keratinocytes similar to that found in 
skin, a well differentiated epithelium and complete epithelial re-
constitution following wounding [22]. In this culture system re-ep-
ithelialization occurs in a manner very similar to that seen in full-
thickness incisional wounds in villa [23]. Re-epithelialization is 
initiated by keratinocyte migration and followed by a transient pro-
liferative burst at the wound margin. Within 24 h wound coverage 
is complete. Using this model, it is possible to investigate the effects 
ofTGF-p1 on the regulation of keratinocyte proliferation and mi-
gration during re-epithelialization. 
MATERIALS AND METHODS 
Cell CultUre Human epidermal keratinocytes were initally culrured 
frol11 newbotn foreskin by the method of Rheinwald and Green (24) in 
keratinocyte medium described by Wu et al [25]. Culrures were established 
through trypsinization of foreskin fragments. 3T3 cells were maintained in 
Dulbecco's modified Eagle's medium (DMEM) containing 10% bovine 
serum. 
Composite Organotypic Co-Cultures and Re-Epithelialization 
Assay Organotypic coculrures were prepared by adapting the protocol 
developed by Organogenesis Inc. [26). Organotypic culrures were modified 
in the following way. After 6 d the composite co-culture was raised to the 
air-liquid interface and fed from below with epidermal growth medium 
(Organogenesis Inc., Canton, MA) for an additional 4 d. At this time, cul-
tures were wbunded with a scalpel incision 1.2 cm in length that completely 
penetrated the epidermis and collagen matrix. These incised culrures were 
detached from their polycarbonate membrane and transferred with a dental 
mirror to carry the culture to a second collagen matrix. This second 
0022-202X/94/S07.00 Copyright © 1994 by The Society for Investigative Dermatology, Inc. 
554 
VOL. 103, NO.4 OCTOBER 1994 
. IGrp. 24 fI .tGr,R.24 h 
2] © POR-. outukd I CD ~ DO cO 000 Dc 0 0 0,0 DD~cUo a 0 a 
mm 0 
" 
22 
" " " " 
77 
" 
mm 0 
" " " 
44 
" 
66 n 
" 
Figure 1. Pattern of keratinocyte proliferation in marginal and 
wound epithelium with and without TGF-B1. A) 24 h post-wounding 
without TGF-fil, B) 8 h post-wounding without TGF-fil, C) 24 h non-
wounded without TGF-fil, D) 24 h post-wounding with TGF-fil, E) 8 h 
post-wounding with TGF-fil, F) 24 h non-wounded with TGF-fil. LI is the 
percentage of basal or immediate suprabasal nuclei labelled with BrdU. X 
axis, each unit length of epithelium (0.375 mm) from counts of three sec-
tions. WM, wound margins as demarcated by arrows. 
matrix was prepared exactly as the first collagen matrix and was cast 6 d 
before transfer of wounds. In this way, re-epithelialization could occur on a 
substrate similar to that on which keratinocytes were originally seeded onto 
the first collagen matrix. A drop of collagen was added to the second colla-
gen matrix to promote adherence of the two matrices. Margins created by 
incision were then separated to form wounds that were 0.18 cm at their 
greatest width. The wounds were elliptical due to the surface tension of the 
organotypic cultures. Cultures were maintained at the air-liquid interface 
during re-epithelialization. Wounds were formalin-fixed and paraffin-em-
bedded at indicated times after wounding and sections were deparallinized 
for histochemical and immunohistochemical staining. 
TGF-fit Lyophilized bovine bone-derived TGF-fil (Celtrix, Palo Alto, 
CA) was prepared as a l-Jlg/ml stock in 5-mg/ml human serum albumin 
(HSA) and stored at -70 °C. To determine the dosage effect ofTGF-fil on 
re-epithelialization , TGF-fil concentrations va.rying from 0.1 to 7 ng/ml 
were added to organotypic co-cultures following wounding for either 24 or 
48 h. Wounded control cultures were grown in media to which 5 mg/ml 
HSA was added. Fresh media containing TGF-fil was added every 8 h to 
ensure that it was not inactivated. As controls, non-wounded cultures were 
grown as described both with and without TGF-fi1. 
BrdU Incorporation Assay Bromodeoxyuridine (10 11m) (Sigma, St. 
Louis, MO) was incubated with wounded organotypic co-cultures for 8 h. 
S-phase nuclei incorporating BrdU were detected using a monoclonal anti-
BrdU antibody [27J (Boehringer-Mannheim, Indianapolis, IN) after sec-
tions were deparallinized, digested with 0.4 mg/ml pepsin in 0.1 N HCI, 
and denatured in 2 N HCI for 20 min. The number ofBrdU-positive nuclei 
in a basal or immediately suprabasal position per ullit length of 0.375 mm 
was counted and an average obtained for three sections in series. The labeling 
index (LI) represents the percentage of BrdU-positive basal cells. 
RESULTS 
Re-Epithelialization With and Without TGF-p1 In the ab-
scence ofTGF-fil, the first response noted at 8 h was an increase in 
proliferation compared to non-wounded epithelium (Fig 1B,C) 
al though little movement of cells onto the denuded surface was seen 
(Fig 2a). No significant differences in proliferation were seen at 
this time with or without TGF-fil (Fig 1B,E). By 24 h, the wound 
surface was covered with an epithelium of one to three cell layers 
(Fig 2b) and a marked increase in proliferation was evident (Fig 1A 
and 3a). By 48 h, the re-epithelialized area had stratified more 
completely (Fig 2c). 
The addition of 2.5 ng/ml TGF-fil to cultures at the time of 
wounding delayed re-epithelialization and reduced hyperprolifera-
tion. At 8 h post-wounding, cultures treated with TGF-fil appeared 
similar to those not treated with TGF-fil (Fig 2a,d) . However, at 
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24 h, when non-treated cui rures had re-epithelialized (Fig 2b), 
TGF-fil treated cultures showed only a thin tongue of elongated 
cells moving onto the wound surface (Fig 2e) . Proliferation in this 
tongue, as detected by BrdU incorporation, was considerably lower 
tban that seen in the wound epithelium that was not treated with 
TGF-fil (Fig 3a,b). However, a hyperproliferative state was main-
tained in the presence of TGF-fil at 24 h, as LI continued to be 
threefold higher than that seen in non-wounded epithelium (Fig 
tC,D). By 48 h, however, re-epithelialization was complete in 
TGF-fil-treated cultures (Fig 2j). 
Dose-Dependent Effect of" TGF-pt on Re-Epithelialization 
At increasing concentrations of TGF-fil, a progressively greater 
delay in re-epithelialization was observed 24 h after wounding. In 
the presence of the lowest concentration of TGF-fil (0.1 ng/ml) , 
the wounds were re-epithelialized and stratified within 24 h (Fig 
4a). When 1 ng/ml TGF-fil was added, re-epithelialization was 
complete by 24 h but little stratification of the re-epithelialized 
surface had occurred (Fig 4b) . At 2.5 and 7 ng/ml, re-epithelializa-
tion was incomplete at 24 h (Figs 2e and 4c). By 48 h complete 
re-epithelialization and stratification had occurred at all TGF-fil 
concentrations (Figs 2f and 4d,e,J). TGF-fil therefore induced a 
dose-dependent delay of re-epithelialization. 
The hyperproliferative response of the wounded epithelium at 24 
h was reduced when the dose ofTGF-Pl was raised from 1 ng/ml 
(Fig 5B) to 2.5 ng/m] (Fig tV) and may partially explain the delay 
in re-epithelialization seen in the latter condition. No significant 
differences were seen in proliferation in the wound defect for 0.1 
and 1 ng/ml TGF-fil at both 24 and 48 h (Fig 5A,B,E,F). How-
ever, at 7 ng/ml, proliferation was markedly reduced at 24 h to a 
level similar to that observed in non-wounded cultures (Fig 5C,D). 
Proliferation of wounded cultures was nearly completely inhibited 
at 48 h (Fig 5G). In spite of this proliferation inhibition, re-epi-
thelialization and stratification were complete by 48 h in the pres-
ence 00 ng/ml TGF-fil (Fig 4f), suggesting that re-epithelializa-
tion seen at this concentration must be due to migration of 
keratinocytes. 
DISCUSSION 
We observed that TGF-fil induced a dose-dependent delay in re-
epithelialization that may be due to a reduced hyperproliferative 
response in the wounded epithelium. Even though proliferation 
was somewhat lowered when wounded keratinocytes were cultured 
with 2.5 ng/ml TGF-fil, the LI was roughly twelvefold higher 
than non-wounded control cultures grown at this TGF-fil dose 
(Fig IF versus D). A similarly elevated LI was seen when wounded 
cultures and non-wounded cultures grown without TGF-fil were 
compared (Fig lA versus C). This suggests that wounded kerati-
nocytes were refractory to the TGF-fil jnhibition of proliferation 
reported in organotypic culture [28] . A similar finding has been 
reported ill lIillo in full-thickn.ess wounds in rabbits [3]. At higher 
levels of TGF-fil (7 ng/ml) we found complete suppression of 
proliferation at 48 h post-wounding. Stimulatory and inhibitory 
effects ofTGF-fil on proliferation in the same cell type have been 
previously described [29]. It therefore appears that TGF-fil demon-
strates a dose-dependent inhibition of proliferation of wounded epi-
thelium in the organotypic culture model described. 
Such a dose-dependent suppression of keratinocyte proliferation 
was initially reported by Shipley et al [9] and later found by other 
authors [10,11] . In the study of Shipley et aI, 3 ng/ml TGF-fil was 
shown to slightly inhibit keratinocyte growth whereas 10 ng/mJ 
caused almost complete keratinocyte inhibition. In this study, we 
observed similar suppression effects ofTGF-fil at close to the same 
doses. This suggests that hyperproliferative conditions, such as 
those under which submerged and wounded cultures are grown, 
require a higher TGF-fil dose to block their proliferation. On the 
other hand, organotypic cultures, which are not hyperproliferative, 
have been shown in the current study to be completely suppressed 
even at lower doses (2 .5 ng/ml) ofTGF-fi1. 
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Figure 2. Effect ofTGF-jJl on re-epithelialization. Wounded cultures grown withoutTGF-jJl and studied at a) 8 h, b) 24 h, and c) 48 h post-wounding. 
Cultures grown with 2.5 ng/ml TGF-jJl and studied at d) 8 h, e) 24h, and j) 48 h. Without TGF-jJl, re-epithelialization was complete after 24 h, although it 
was incomplete in the presence ofTGF-J11. By 48 h, both wounds had completely re-epithelialized and stratified. Wound margins and demarcated by arrows. 
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Figure 3. Kcratinocyte proliferation at wound margin 24 h after wounding. a) Without TGF-jJl, cells in the wound margin and wound epithelium 
show high proliferative activity. b) With 2.5 ng/ml TGF-jJl, proliferation is lower in the wound margin and the elongated cells in the thin epithelial tongue 
(thin arrows) did not show proliferative activity. Thick arrows demarcate wound margins. Cultures were incubated in 10 J.l.M BrdU for 8 h prior to harvesting and 
stained with a monoclonal antibody to BrdU. 
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Figure 4. Dosage effect ofTGF-fit on re-epithelialization. Re-epithelialization was analyzed at 24 h with II) 0.1 ng/ml, b) 1 ng/ml, and c) 7 ng/ml 
TGF-fil and at 48 h with d) 0.1 ng/ml, e) 1 ng/ml, and J) 7 ng/ml TGF-fil. Arrows demarcate wound margins. 
Two mechanisms can be suggested to explain the refractory na-
ture of wounded keratinocytes to TGF-pl proliferation inhibition. 
First, a keratinocyte phenotype may be generated that is not sensi-
tive to TGF-Pl proliferation inhibition. This response is similar to 
that first reported for a squamous carcinoma cell line [9]. In addi-
tion, a similar response was noted in other squamous cell carcinoma 
lines [1] and for transformed keratinocytes [30]. The demonstration 
of this phenotype in wounded and transformed cells suggests simi-
larities between the processes of wound healing and carcinogenesis 
[31]' This loss of sensitivity to TGF-p1 growth inhibition in trans-
formed cells has been associated with the negative regulation of 
c-myc transcription [32] . The molecular mechanisms explaining 
the refractory nature of wounded keratinocytes to TGF-p1 growth 
inhibition remains to be elucidated. 
Alternatively, TGF-p1 may act as an indirect mitogen [29] to 
stimulate fibroblast secretion of paracrine-acting factors that in turn 
overcome the TG F-P1 - induced growth inhibition ofkeratinocytes 
[10,13]. This mechanism is unlikely to be responsible for this phe-
nomena because elevated keratinocyte proliferation is not observed 
in the presence of TGF-pl in non-wounded cultures that contain 
fibroblasts [28]. However, it is possible that wounding increases 
fibroblast production of paracrine-acting growth factors that over-
come the growth-inhibitory effects of TGF-p1 on keratinocytes. 
The effect of TGF-p1 on migration was assessed by evaluating 
re-epithelialization and stratification in the absence of proliferation. 
When 7 ng/ml TGF-Pl was added to cultures, proliferation was 
profoundly inhibited between 24 and 48 h post-wounding, yet re-
epithelialization and stratification were complete. Enhanced cell 
migration is the most plausible explanation for the fully thickened 
and stratified epithelium in the face of such marked keratinocyte 
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Figure 5. Pattern of keratinocyte proliferation in marginal and 
wound epithelium at 24 and 48 hours with varied dose ofTGF-p. A) 
Wounded culture with 0.1 ng/ml TGF-p at 24 h, B) wounded culture with 
1 ng/ml TGF-p at 24 h. C) wounded cultures with 7 ng/ml TGF-p at 24 h, 
D) non-wounded culture without TGF-p at 48 h, E) wounded culture with 
0.1 ng/ml TGF-p at 48 h, F) wounded culture with 1 ng/ml TGF-p at 48 h. 
G) wounded cultures with 7 ng/ml TGF-pat 48 h. H) non-wounded culture 
with 2.5 ng/ml TGF-p at 48 h. LI is the percentage of basal or immediately 
suprabasal nuclei labeled with BrdU. X axis. unit length of epithelium from 
counts of three sections. Slashed bars, wound defect; open bars, non-wounded 
epithelium. The average of LI is shown for each and the error bars are ranges 
for individual LI measurements in each area. 
proliferative inhibition [29]. TGF-p1 has previously been shown to 
activate keratinocytes by shifting the character of the cell away from 
proliferation and towards locomotion [33] . 
In submerged cultures, both enhancement [34] and suppression 
[10] of epithelial cell migration by TGF-p1 has been shown. In 
organ cultures of pig skin. Hebda described the effect ofTGF-pl on 
re-epithelialization as leading to an earlier initiation ofkeratinocyte 
outgrowth without a concomitant increase in mitotic activity [35]. 
In addition, in vivo investigations show that TGF-p1 induces an 
increase in keratinocyte motility, attachment, and spreading over 
the dermis and an increased rate of epidermal cell migration after 
wounding [3 ,11]. The varied migratory responses of keratinocytes 
to TGF-p1 seen in submerged cultures as compared to previous in 
vivo findings and to our study may be explained by the fact that 
submerged cultures contain a high proportion of cells with a basal 
character, which may show a different migratory response than 
keratinocytes in a fully differentiated epithelium. 
Our results demonstrate that TGF-pl alters re-epithelialization 
by modifying proliferation and migration. These effects are coin-
cident with the switch from a normal to a regenerative epithelial 
cell phenotype that occurs following wounding and is characterized 
by elevated proliferation. TGF-p1 may then modulate this altered 
cell phenotype by exerting dose-dependent effects on proliferation 
and migration. These effects may be temporally related and may 
variably affect different stages of re-epithelialization. Our findings 
support itl vivo effects of TGF-pl on the wound environment in-
cluding enhanced migration and a dose-dependent effect on epider-
mal regeneration. 
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